{
    "eid": "2-s2.0-85103089941",
    "title": "Bibenzyl analogue DS-1 inhibits MDM2-mediated p53 degradation and sensitizes apoptosis in lung cancer cells",
    "cover-date": "2021-05-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Pharmaceutical Science",
            "@code": "3003",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Complementary and Alternative Medicine",
            "@code": "2707",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Bibenzyl",
        "Chemosensitizer",
        "DS-1",
        "Lung cancer",
        "MDM2",
        "p53"
    ],
    "authors": [
        "Hardyanti Eka Putri",
        "Bodee Nutho",
        "Thanyada Rungrotmongkol",
        "Boonchoo Sritularak",
        "Chanida Vinayanuwattikun",
        "Pithi Chanvorachote"
    ],
    "citedby-count": 9,
    "ref-count": 65,
    "ref-list": [
        "Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1",
        "Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1",
        "How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?",
        "Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature",
        "Restoration of wild-type p53 function in human cancer: relevance for tumor therapy",
        "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries",
        "The MDM2 Inhibitor AMG 232 Demonstrates Robust Antitumor Efficacy and Potentiates the Activity of p53-Inducing Cytotoxic Agents",
        "Inhibiting the p53\u2013MDM2 interaction: an important target for cancer therapy",
        "Platinum drugs in the treatment of non-small-cell lung cancer",
        "The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer",
        "Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours",
        "Census and evaluation of p53 target genes",
        "Control of apoptosis by p53",
        "Molecular mechanisms of cisplatin resistance",
        "Increasing p53 protein sensitizes non-small cell lung cancer to paclitaxel and cisplatin in vitro",
        "Inhibiting MDM2-p53 Interaction Suppresses Tumor Growth in Patient-Derived Non-Small Cell Lung Cancer Xenograft Models",
        "p73 and MDM2 confer the resistance of epidermoid carcinoma to cisplatin by blocking p53",
        "The role of p53 in cancer drug resistance and targeted chemotherapy",
        "MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation",
        "The best platinum regimens for chemo-naive incurable non-small cell lung cancer: network meta-analysis",
        "The role of MDM2 amplification and overexpression in therapeutic resistance of malignant tumors",
        "Patient-derived cell line, xenograft and organoid models in lung cancer therapy",
        "The Regulation of Multiple p53 Stress Responses is Mediated through MDM2",
        "The mutant p53 mouse as a pre-clinical model",
        "Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis",
        "Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53",
        "Putting p53 in Context",
        "Reactivation of p53 via MDM2 inhibition",
        "Targeting the p53\u2013MDM2 interaction to treat cancer",
        "p53 regulation upon genotoxic stress: intricacies and complexities",
        "Transcriptional regulation by p53: one protein, many possibilities",
        "The complexity of p53 stabilization and activation",
        "Regulation of p53 localization",
        "Abnormal gametogenesis induced by p53 deficiency promotes tumor progression and drug resistance",
        "Deletions linked to TP53 loss drive cancer through p53-independent mechanisms",
        "Mdm2-mediated ubiquitylation: p53 and beyond",
        "Restoring p53 tumor suppressor activity as an anticancer therapeutic strategy",
        "Identification and cloning of a novel amplified DNA sequence in human malignant fibrous histiocytoma derived from a region of chromosome 12 frequently rearranged in soft tissue tumors",
        "Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis",
        "A New Bibenzyl-phenanthrene Derivative from Dendrobium signatum and its Cytotoxic Activity",
        "Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship",
        "The MDM2-p53 interaction",
        "The Roles of p53 in Mitochondrial Dynamics and Cancer Metabolism: the Pendulum between Survival and Death in Breast Cancer?",
        "MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines",
        "The Role of MDM2 Amplification and Overexpression in Tumorigenesis",
        "Role of p53 in Cell Death and Human Cancers",
        "Limiting the power of p53 through the ubiquitin proteasome pathway",
        "MDM2 and human malignancies: expression, clinical pathology, prognostic markers, and implications for chemotherapy",
        "p53 and disease: when the guardian angel fails",
        "Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin",
        "Targeting the MDM2-p53 interaction for cancer therapy",
        "Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy",
        "Cooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer",
        "Dual Roles of MDM2 in the Regulation of p53: ubiquitination Dependent and Ubiquitination Independent Mechanisms of MDM2 Repression of p53 Activity",
        "Cisplatin: mode of cytotoxic action and molecular basis of resistance",
        "A small molecule that disrupts Mdm2-p53 binding activates p53, induces apoptosis and sensitizes lung cancer cells to chemotherapy",
        "Cytogenetic studies of adipose tissue tumors. II. Recurrent reciprocal translocation t(12;16)(q13;p11) in myxoid liposarcomas",
        "MDM2, MDMX and p53 in oncogenesis and cancer therapy",
        "MDM2 inhibitor Nutlin-3a suppresses proliferation and promotes apoptosis in osteosarcoma cells",
        "Nitroxoline induces cell apoptosis by inducing MDM2 degradation in small-cell lung cancer",
        "Mutant p53 in Cancer: accumulation, Gain-of-Function, and Therapy",
        "Non-small cell lung cancer: current treatment and future advances",
        "Small-molecule inhibitors of the MDM2-p53 protein-protein interaction (MDM2 Inhibitors) in clinical trials for cancer treatment",
        "p53 sensitizes chemoresistant non-small cell lung cancer via elevation of reactive oxygen species and suppression of EGFR/PI3K/AKT signaling",
        "The regulation of MDM2 oncogene and its impact on human cancers"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60012718",
            "affilname": "Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chulalongkorn University",
        "Thailand Research Fund"
    ]
}